216 related articles for article (PubMed ID: 15490352)
1. [Psychiatric complications of Parkinson's disease: their symptoms and treatment].
Castro-García A; Sesar-Ignacio A; Ares-Pensado B
Rev Neurol; 2004 Oct 1-15; 39(7):646-50. PubMed ID: 15490352
[TBL] [Abstract][Full Text] [Related]
2. [Psychiatric complications of L-dopa: physiopathology and treatment].
Castro-García A
Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
[TBL] [Abstract][Full Text] [Related]
3. Intervening in the neuropsychiatric features of Parkinson's disease.
Weintraub D; Stern MB
Expert Rev Neurother; 2007 Jun; 7(6):699-710. PubMed ID: 17563252
[TBL] [Abstract][Full Text] [Related]
4. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Parkinson's disease. Psychological disorders: striking a balance in order to optimise antiparkinsonian treatment.
Prescrire Int; 2011 Oct; 20(120):242-5. PubMed ID: 21970092
[TBL] [Abstract][Full Text] [Related]
6. Management of the behavioral aspects of Parkinson's disease.
Borek LL; Chou KL; Friedman JH
Expert Rev Neurother; 2007 Jun; 7(6):711-25. PubMed ID: 17563253
[TBL] [Abstract][Full Text] [Related]
7. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
Chen JJ
Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
[No Abstract] [Full Text] [Related]
8. [Cognitive and neuropsychiatric disorders in Parkinson's disease].
Rodríguez-Constenla I; Cabo-López I; Bellas-Lamas P; Cebrián E
Rev Neurol; 2010 Feb; 50 Suppl 2():S33-9. PubMed ID: 20205140
[TBL] [Abstract][Full Text] [Related]
9. [Neuropsychiatric disorders in Parkinson's disease].
Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
[TBL] [Abstract][Full Text] [Related]
10. [Emotional and cognitive disorders in Parkinson disease].
Arsland D; Larsen JP
Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3959-63. PubMed ID: 9830342
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Meco G; Bernardi S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
[TBL] [Abstract][Full Text] [Related]
12. Psychosis in nursing home patients with Parkinson's disease.
Kang GA; Bronstein JM
J Am Med Dir Assoc; 2004; 5(3):167-73. PubMed ID: 15115577
[TBL] [Abstract][Full Text] [Related]
13. [Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S; Ardouin C; Schmitt E; Lhommée E; Klinger H; Xie J; Lagrange C; Kistner A; Aya Kombo M; Fleury V; Poisson A; Fraix V; Broussolle E; Pollak P; Krack P
Rev Neurol (Paris); 2010 Oct; 166(10):816-21. PubMed ID: 20739041
[TBL] [Abstract][Full Text] [Related]
14. The impact and management of nonmotor symptoms of Parkinson's disease.
Lyons KE; Pahwa R
Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
[TBL] [Abstract][Full Text] [Related]
15. [Psychiatric and cognitive complications arising from subthalamic stimulation in Parkinson's disease].
Castro-García A; Sesar-Ignacio A; Ares-Pensado B; Relova-Quinteiro JL; Gelabert-González M; Rumbo RM; Noya-García M
Rev Neurol; 2006 Aug 16-31; 43(4):218-22. PubMed ID: 16883511
[TBL] [Abstract][Full Text] [Related]
16. When a Parkinson's disease patient starts to hallucinate.
Poewe W
Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
[TBL] [Abstract][Full Text] [Related]
17. Drug treatments for the neuropsychiatric complications of Parkinson's disease.
Connolly BS; Fox SH
Expert Rev Neurother; 2012 Dec; 12(12):1439-49. PubMed ID: 23237351
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric syndromes in Parkinson's disease.
Starkstein SE; Brockman S; Hayhow BD
Curr Opin Psychiatry; 2012 Nov; 25(6):468-72. PubMed ID: 22992542
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric complications in the treatment of Parkinson's disease.
Wolters EC
Adv Neurol; 2001; 86():385-93. PubMed ID: 11554000
[No Abstract] [Full Text] [Related]
20. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
